Results 71 to 80 of about 2,438,474 (193)

Drug resistance-conferring mutations in Mycobacterium tuberculosis from Madang, Papua New Guinea [PDF]

open access: yes, 2012
: BACKGROUND: Monitoring drug resistance in Mycobacterium tuberculosis is essential to curb the spread of tuberculosis (TB). Unfortunately, drug susceptibility testing is currently not available in Papua New Guinea (PNG) and that impairs TB control in ...
Gagneux, S.   +47 more
core   +1 more source

Multidrug Resistance Profiling of Some Bacterial Pathogens from Mobile Phones of Health Workers and Surfaces of Kwara State University (KWASU) Health Centre

open access: yesUMYU Journal of Microbiology Research
Multidrug resistance (MDR) is a major public health challenge, and the direct and indirect transmission of these resistant pathogens can occur via healthcare centre surfaces and the phones of healthcare personnel.
Lateefah Uthman-Saheed   +1 more
doaj   +1 more source

Prevalence of carbapenem resistance among multidrug-resistant Gram-negative uropathogens

open access: yesArchives of Pharmaceutical Sciences Ain Shams University, 2018
Multidrug-resistant (MDR) uropathogens have become a public health threat, especially in developing countries. Carbapenems are a class of antimicrobial agents often reserved for infections caused by MDR microorganisms.
Ann A. Elshamy   +3 more
doaj   +1 more source

PRIMARY MULTIDRUG RESISTANCE OF TUBERCULOSIS MYCOBACTERIUM ACCORDING TO DATA OF KRASNOYARSK REGIONAL TUBERCULOSIS DISPENSARY № 1 IN-PATIENT DEPARTMENT

open access: yesActa Biomedica Scientifica, 2012
This study of multidrug resistance (MDR) of tuberculosis mycobacterium. (TMB) frequency has revealed, that in 2011 28,4 % persons discharging bacteria with, newly diagnosed pulmonary tuberculosis had multidrug resistance of tuberculosis mycobacterium and
N. M. Koretskaya, A. N. Narkevich
doaj  

Effects of Myristicin in Association with Chemotherapies on the Reversal of the Multidrug Resistance (MDR) Mechanism in Cancer. [PDF]

open access: yesPharmaceuticals (Basel), 2022
Seneme EF   +5 more
europepmc   +1 more source

Multidrug Resistance

open access: yes, 2019
In this chapter we cover non-specific, intrinsic multidrug-resistance (MDR), which provides bacteria with protection from a wide spectrum of xenobiotic compounds, including medically relevant antibiotics. There are two main components to this resistance –
Marshall, Robert L   +3 more
core   +1 more source

Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment

open access: yesEmerging Infectious Diseases
High-dose isoniazid is recommended to treat multidrug-resistant tuberculosis (MDR TB). Among 958 MDR TB isolates identified in France during 2008–2022, 93.1% exhibited high-level isoniazid resistance, and molecular testing showed limited diagnostic ...
Valentina Gerussi   +14 more
doaj   +1 more source

Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs. [PDF]

open access: yes, 2011
BACKGROUND: Sudan is a large country with a diverse population and history of civil conflict. Poverty levels are high with a gross national income per capita of less than two thousand dollars.
Bottomley, Christian   +23 more
core   +2 more sources

Home - About - Disclaimer - Privacy